ArticleClinical kidney journal2018
Cost of hemodialysis in a public sector tertiary hospital of India.
Article in Clinical kidney journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed.
- Article
- Review
- Transforming hemodialysis access in Kenya: a national assessment of the Managed Equipment Services model.BMC health services research · 2026Article
- Chronic kidney disease in India: Incidence, prevalence, mortality, DALYs, and State-level disparities, 1990-2023.The Indian journal of medical research · 2026Article
- Nephrology in Turbulence: Workforce Strain, Dialysis Gaps, and System Fragility in Nepal After the 2025 Gen Z Protests.Kidney international reports · 2026Article
- Cost of Delivering National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Disease and Stroke Services in the Primary Level of Health Care in Puducherry District of India.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2026Article
- Comparative Assessment of Out-of-Pocket Health Expenditure in Haemodialysis and Peritoneal Dialysis Patients.Healthcare (Basel, Switzerland) · 2025Article
- Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure.Nature reviews. Nephrology · 2025Review
- Out of Pocket Expenditure among Critical Care Insured Patients Admitted in a Tertiary Care Hospital in Coastal Karnataka, India: A Cross-Sectional Study.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2025Article
- Cost-benefit analysis of haemodialysis in patients with end-stage kidney disease in Abuja, Nigeria.Health economics review · 2024Article
- Healthcare Cost of Cochlear Implantation in India.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024Article
- Article
- Willingness to pay for haemodialysis among patients with chronic kidney disease in Abuja, Nigeria.BMC nephrology · 2024Article
- Cost analysis of the management of end-stage renal disease patients in Abuja, Nigeria.Cost effectiveness and resource allocation : C/E · 2023Article
- Cost-effectiveness of population-based screening for microalbuminuria in people with type 2 diabetes mellitus in India.International journal of technology assessment in health care · 2023Article
- Review on kidney diseases: types, treatment and potential of stem cell therapy.Renal replacement therapy · 2023Review
- Accessibility and quality of haemodialysis services in an urban setting in South India: a qualitative multiperspective study.BMJ open · 2022Article
- Peritoneal dialysis-first initiative in India: a cost-effectiveness analysis.Clinical kidney journal · 2022Article
- Safety and utility of kidney biopsy in patients with estimated glomerular filtration rate < 30 ml/min/1.73 mNephrology (Carlton, Vic.) · 2021Article
- International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in South Asia.Kidney international supplements · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionNearly 220000 patients are diagnosed with end-stage renal disease (ESRD) every year, which calls for an additional demand of 34 million dialysis sessions in India. The government of India has announced a National Dialysis Programme to provide for free dialysis in public hospitals. In this article we estimate the overall cost of performing hemodialysis (HD) in a tertiary care hospital. Second, we assess the catastrophic impact of out-of-pocket expenditures (OOPEs) for HD on households and its determinants.
methodsThe economic health system cost of HD was estimated using bottom-up costing methods. All resources, capital and recurrent, utilized for service delivery from April 2015 to March 2016 were identified, measured and valued. Capital costs were annualized after accounting for their useful life and discounting at 3% for future years. Sensitivity analyses were undertaken to determine the effect of variation in the input prices and other assumptions on the annual health system cost. OOPEs were assessed by interviewing 108 patients undergoing HD in the study hospital to account for costs from the patient's perspective. The prevalence of catastrophic health expenditures (CHEs) was computed per threshold of 40% of non-food expenditures.
resultsThe overall average cost incurred by the health system per HD session was INR 4148 (US$64). Adjusting for capacity utilization, the health system incurred INR 3025 (US$47) per HD at 100% bed occupancy. The mean OOPE per patient per session was INR 2838 (US$44; 95% confidence interval US$34-55). The major components of this OOPE were medicines and consumables (64.1%). The prevalence of a CHE per HD session was 11.1%.
conclusionOur study findings would be useful in the context of planning for dialysis services, setting provider payment rates for dialysis under various publicly sponsored health insurance schemes and undertaking future cost-effectiveness analysis to guide resource allocation decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.